Abstract
A neonate with pulmonary interstitial glycogenosis, pulmonary hypertension, and hypertrophic cardiomyopathy is described. The fatal outcome for this patient contrasts with the reported favorable prognosis associated with isolated pulmonary interstitial glycogenosis. To the authors’ knowledge, the association of pulmonary interstitial glycogenosis and hypertrophic cardiomyopathy has not been reported previously. The authors have broadened the phenotype of pulmonary interstitial glycogenosis and demonstrate the diagnostic value of lung biopsy in cases of unexplained neonatal pulmonary hypertension.
References
Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS (2006) Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 8:297–301. doi:10.1097/01.gim.0000195896.04069.5f
Breitweser JA, Meyer RA, Sperling MA, Tsang RC, Kaplan S (1980) Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr 96(3 Pt 2):535–539
Canakis AM, Cutz E, Manson D, O’Brodovich H (2002) Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med 165:1557–1565
Castillo M, Vade A, Lim-Dunham JE, Masuda E, Massarani-Wafai R (2010) Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation. Pediatr Radiol 40:1562–1565. doi:10.1007/s00247-010-1670-2
Deutsch GH, Young LR (2009) Histologic resolution of pulmonary interstitial glycogenosis. Pediatr Dev Pathol 12:475–480. doi:10.2350/08-12-0575.1
Deutsch GH, Young LR (2010) Pulmonary interstitial glycogenosis: words of caution. Pediatr Radiol 40:1471–1475. doi:10.1007/s00247-010-1730-7
Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, Albright EA, Askin FB, Baker P, Chou PM, Cool CM, Coventry SC, Cutz E, Davis MM, Dishop MK, Galambos C, Patterson K, Travis WD, Wert SE, White FV (2007) Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 176:1120–1128. doi:10.1164/rccm.200703-393OC
Dinwiddie R, Sharief N, Crawford O (2002) Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol 34:23–29. doi:10.1002/ppul.10125
Dworzak F, Casazza F, Mora M, De Maria R, Gronda E, Baroldi G, Rimoldi M, Morandi L, Cornelio F (1994) Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant. Neuromuscul Disord 4:243–247
Faienza MF, Giordani L, Ferraris M, Bona G, Cavallo L (2009) PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? Pediatr Cardiol 30:1012–1015. doi:10.1007/s00246-009-9473-7
Fan LL, Kozinetz CA (1997) Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 156(3 Pt 1):939–942
Israel BA, Sherman FS, Guthrie RD (1993) Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 10:307–310. doi:10.1055/s-2007-994747
Lanfranchi M, Allbery SM, Wheelock L, Perry D (2010) Pulmonary interstitial glycogenosis. Pediatr Radiol 40:361–365. doi:10.1007/s00247-009-1455-7
Nishikawa T, Ishiyama S, Shimojo T, Takeda K, Kasajima T, Momma K (1996) Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatr Jpn 38:91–98
Onland W, Molenaar JJ, Leguit RJ, van Nierop JC, Noorduyn LA, van Rijn RR, Geukers VG (2005) Pulmonary interstitial glycogenosis in identical twins. Pediatr Pulmonol 40:362–366. doi:10.1002/ppul.20255
Schroeder SA, Shannon DC, Mark EJ (1992) Cellular interstitial pneumonitis in infants: a clinicopathologic study. Chest 101:1065–1069
Sengers RC, Stadhouders AM, van Lakwijk-Vondrovicova E, Kubat K, Ruitenbeek W (1985) Hypertrophic cardiomyopathy associated with a mitochondrial myopathy of voluntary muscles and congenital cataract. Br Heart J 54:543–547
Smets K, Van Daele S (2011) Neonatal pulmonary interstitial glycogenosis in a patient with Hunter syndrome. Eur J Pediatr 170:1083–1084. doi:10.1007/s00431-011-1444-3
Smets K, Dhaene K, Schelstraete P, Meersschaut V, Vanhaesebrouck P (2004) Neonatal pulmonary interstitial glycogen accumulation disorder. Eur J Pediatr 163:408–409. doi:10.1007/s00431-004-1450-9
Tomita H, Fuse S, Ikeda K, Matsuda K, Chiba S (1998) An infant with Costello syndrome complicated with fatal hypertrophic obstructive cardiomyopathy. Acta Paediatr Jpn 40:608–611
Vaillant MC, Chantepie A, Casasoprana A, Chamboux C, Suc AL, Gold F, Laugier J (1997) Transient hypertrophic cardiomyopathy in neonates after acute fetal distress. Pediatr Cardiol 18:52–56
van der Ploeg AT, Reuser AJ (2008) Pompe’s disease. Lancet 372:1342–1353. doi:10.1016/S0140-6736(08)61555-X
Wadhawan R, Khanna P, Nora F, Gilbert-Barness E (2008) Clinicopathologic conference: persistent tachypnea in a 5-week-old boy. Fetal Pediatr Pathol 27:185–196. doi:10.1080/15513810802319343
Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120(2 Pt 1):286–291
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alkhorayyef, A., Ryerson, L., Chan, A. et al. Pulmonary Interstitial Glycogenosis Associated With Pulmonary Hypertension and Hypertrophic Cardiomyopathy. Pediatr Cardiol 34, 462–466 (2013). https://doi.org/10.1007/s00246-012-0311-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0311-y